Christoph Wanke

1.7k total citations · 1 hit paper
17 papers, 1.3k citations indexed

About

Christoph Wanke is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Christoph Wanke has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Christoph Wanke's work include Carbohydrate Chemistry and Synthesis (4 papers), Gastrointestinal motility and disorders (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Christoph Wanke is often cited by papers focused on Carbohydrate Chemistry and Synthesis (4 papers), Gastrointestinal motility and disorders (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Christoph Wanke collaborates with scholars based in Switzerland, Germany and Netherlands. Christoph Wanke's co-authors include V.P. Iordanov, Jeff Shimizu, D. E. Becker, Nikolaus Amrhein, Wolfgang Budach, Mirko Koziolek, Grzegorz Garbacz, Werner Weitschies, Michael Grimm and Gerhard H. Braus and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Christoph Wanke

17 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System

2014 348 citations Mirko Koziolek, Michael Grimm et al. Journal of Pharmaceutical Sciences profile →

Peers

Countries citing papers authored by Christoph Wanke

Since Specialization

Citations

This map shows the geographic impact of Christoph Wanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Wanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Wanke more than expected).

Fields of papers citing papers by Christoph Wanke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Wanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Wanke. The network helps show where Christoph Wanke may publish in the future.

Co-authorship network of co-authors of Christoph Wanke

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Wanke. A scholar is included among the top collaborators of Christoph Wanke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Wanke. Christoph Wanke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets 2015 ·PLoS ONE ·(unknown), R.C.A. Schellekens, (unknown), Christoph Wanke, V.P. Iordanov, Frans Stellaard, Klaus D. Wutzke, Gerard Dijkstra, (unknown), Herman J. Woerdenbag, Henderik W. Frijlink, Jos G. W. Kosterink	106
2	Validation of the IntelliCap® system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drug 2015 ·Journal of Controlled Release ·Erik Söderlind, Bertil Abrahamsson, Fredrik Erlandsson, Christoph Wanke, V.P. Iordanov, Christian von Corswant	36
3	Novel Orally Swallowable IntelliCap® Device to Quantify Regional Drug Absorption in Human GI Tract Using Diltiazem as Model Drug 2014 ·AAPS PharmSciTech ·D. E. Becker, Jin Zhang, Tycho Heimbach, Robert C. Penland, Christoph Wanke, Jeff Shimizu, Kenneth Kulmatycki	75
4	Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System breakdown → 2014 ·Journal of Pharmaceutical Sciences ·Mirko Koziolek, Michael Grimm, D. E. Becker, V.P. Iordanov, (unknown), Jeff Shimizu, Christoph Wanke, Grzegorz Garbacz, Werner Weitschies	348
5	A novel ingestible electronic drug delivery and monitoring device 2013 ·Gastrointestinal Endoscopy ·Peter Schaar, Joshua Dijksman, (unknown), Jeff Shimizu, Niels van Lelyveld, (unknown), V.P. Iordanov, Christoph Wanke, Peter D. Siersema	90
6	First in Human Study With a Novel Ingestible Electronic Drug Delivery and Monitoring Device: The Intellicap 2011 ·Gastroenterology ·Peter Schaar, (unknown), Jeff Shimizu, Christoph Wanke, Peter D. Siersema	7
7	Gender differences in kidney function 2007 ·Pflügers Archiv - European Journal of Physiology ·Ivan Sabolić, Abdul R. Asif, Wolfgang Budach, Christoph Wanke, Andrew Bahn, Gerhard Burckhardt	173
8	Evanescent resonator chips: a universal platform with superior sensitivity for fluorescence-based microarrays 2003 ·Biosensors and Bioelectronics ·D. Neuschäfer, Wolfgang Budach, Christoph Wanke, (unknown)	39
9	Generation of Transducers for Fluorescence-Based Microarrays with Enhanced Sensitivity and Their Application for Gene Expression Profiling 2003 ·Analytical Chemistry ·Wolfgang Budach, D. Neuschäfer, Christoph Wanke, Salah‐Dine Chibout	21
10	Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB 2002 ·Journal of Biological Chemistry ·David Cappellen, (unknown), Sandrine Bongiovanni, Olivier Grenet, Christoph Wanke, Mira Šuša	156
11	c‐Jun and RACK1 homologues regulate a control point for sexual development inAspergillus nidulans 2000 ·Molecular Microbiology ·Bernd Hoffmann, Christoph Wanke, (unknown), Gerhard H. Braus	64
12	Sexual development of Aspergillus nidulans in tryptophan auxotrophic strains 1999 ·Archives of Microbiology ·Sabine Eckert, Bernd Hoffmann, Christoph Wanke, Gerhard H. Braus	42
13	*The Aspergillus nigerGCN4* homologue, cpcA, is transcriptionally regulated and encodes an unusual leucine zipper** 1997 ·Molecular Microbiology ·Christoph Wanke, Sabine Eckert, Gerd Albrecht, W. van Hartingsveldt, Peter J. Punt, Cees A. M. J. J. van den Hondel, Gerhard H. Braus	48
14	Crystallization and Preliminary X-Ray Diffraction Analysis of UDP-N-acetylglucosamine Enolpyruvyltransferase ofEnterobacter cloacae 1996 ·Journal of Structural Biology ·Stefan Sack, Zbigniew Dauter, Christoph Wanke, Nikolaus Amrhein, Eckhard Mandelkow�, E. Schönbrunn	5
15	Detection of the Covalent Intermediate of UDP-N-Acetylglucosamine Enolpyruvyl Transferase by Solution-State and Time-Resolved Solid-State NMR Spectroscopy 1994 ·Biochemistry ·Cecilia A. Ramilo, (unknown), Christoph Wanke, Florian Krekel, Nikolaus Amrhein, Jeremy N. S. Evans	16
16	Evidence that the reaction of the UDP‐N‐acetylglucosamine 1‐carboxyvinyltransferase proceeds through the O‐phosphothioketal of pyruvic acid bound to Cys115 of the enzyme 1993 ·European Journal of Biochemistry ·Christoph Wanke, Nikolaus Amrhein	62
17	The UDP‐N‐acetylglucosamine 1‐carboxyvinyl‐transferase of Enterobacter cloacae Molecular cloning, sequencing of the gene and overexpression of the enzyme 1992 ·FEBS Letters ·Christoph Wanke, Rocco Falchetto, Nikolaus Amrhein	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact